Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
Technology
$216.75 +10.53%
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
52W Low $84.78High $421.13
Volume 4.57M
Average 5.72M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$319.31M
FY 2025 · Annual
+133.6% YoYInvesting Cash Flow
-$241.47M
FY 2025 · Annual
Financing Cash Flow
$9.80M
FY 2025 · Annual
-98.5% YoYCash Flow Statement
USD
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 30.24M | 10.68M | 234.59M | 160.03M |
| Change in Working Capital | (9.97M) | (9.68M) | (13.3M) | (65.96M) |
| Accounts Receivables | (6.04M) | 2.39M | (30.48M) | (44.34M) |
| Inventory | (19.36M) | (5.56M) | (19.29M) | (12.95M) |
| Accounts Payables | 2.13M | (4.26M) | 20.89M | 14.19M |
| Other Working Capital | 13.3M | (2.23M) | 15.59M | (22.87M) |
| Other Non-Cash Items | 1.38M | 10.76M | (4.35M) | (726K) |
| Operating Cash Flow | (35.9M) | (12.72M) | 136.68M | 319.31M |
| Capital Expenditures | (3.87M) | (2.76M) | (34.25M) | (37.54M) |
| Acquisitions (Net) | 0 | 0 | 0 | (28.79M) |
| Purchases of Investments | (88.71M) | (126.23M) | (930.58M) | (857.75M) |
| Sales of Investments | 2M | 111.21M | 208.67M | 683.11M |
| Other Investing Activities | 0 | 0 | (1.41M) | (500K) |
| Investing Cash Flow | (90.59M) | (17.77M) | (757.57M) | (241.47M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 672.2M | 9.8M |
| Common Stock Repurchased | (313K) | (210K) | (1.07M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.12M | (292K) | (15.29M) | 0 |
| Financing Cash Flow | 151.67M | (502K) | 655.84M | 9.8M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.18M | (30.99M) | 34.95M | 87.64M |
| Free Cash Flow | (39.77M) | (15.48M) | 102.43M | 281.76M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$219.1M
+ D&A$6.8M
+ Stock-Based Comp$160.0M
+ Deferred Tax$0
- Working Capital-$66.0M
- Other Non-Cash-$726.0K
= Operating Cash Flow$319.3M
- Capex-$37.5M
= Free Cash Flow$281.8M
Analysis
FY2025 free cash flow is $281.8M. FCF conversion is 128.6% of net income. Operating cash flow was $319.3M, with capex of -$37.5M. The largest bridge item is Stock-Based Comp at $160.0M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 9, 2026 |
Does ALAB generate free cash flow?
Astera Labs, Inc. Common Stock (ALAB) generated $281.76M of free cash flow in fiscal 2025.
How much operating cash flow does ALAB produce?
Operating cash flow was $319.31M, before capital expenditures of $37.54M.
Continue the stock analysis
Jump to another research area for this company.